A research collaboration led by Professor Minah Suh of Sungkyunkwan University's Department of Biomedical Engineering, together with the biotechnology company IMNEWRUN and Professor Ho-Keun Kwon's team at Yonsei University College of Medicine, has uncovered a mechanism linking brain immune balance to Alzheimer's disease. The work points to a possible new direction for treatment by targeting the brain's immune system rather than directly attacking the disease's hallmark proteins.
The team's findings indicate that modulating the activity of brain immune cells could help restore a healthy immune balance, which may in turn slow or alter the course of the disease. While the source does not detail the exact molecular pathway, it describes the discovery as a novel avenue for Alzheimer's intervention.
Because only one source is available, there are no conflicting reports to compare. The study's significance lies in its shift toward immune regulation as a therapeutic target, though further validation would be needed to confirm its clinical potential.